Limula
Limula develops technology to lower the costs of life-saving cell and gene therapy products by automating cell manipulation processes. Their platform aims to make these therapies more accessible by reducing reliance on highly skilled labor and expensive sterile infrastructure. This is achieved through software solutions that support manufacturing workflows impossible to automate with existing tools.
Buy Funded Startups lists
Funding Round: Seed
Funding Amount: $6.8M
Date: 21-May-2024
Investors: LifeX Ventures, Verve Ventures, Zühlke Ventures, Oxford Seed Fund, Lichtsteiner Foundation, W.A. de Vigier Foundation, the founders and angel investors
Markets: Healthtech, Biotechnology, Biotechnology Research, Genetics, Manufacturing, Pharmaceutical
HQ: Epalinges, Vaud, Switzerland
Founded: 2020
Website: https://limula.ch/
LinkedIn: https://www.linkedin.com/company/limula
Twitter: https://twitter.com/LimulaB
Crunchbase: https://www.crunchbase.com/organization/limula-biotech
Leave a Comment
Comments
No comments yet.